Long-awaited protection for tots appears close to arrival. Moderna also get clearance for vaccine for 6- to 17-year olds.
FDA Clears Moderna, Pfizer Covid Shots for Children 5 and Under
Latest News
FDA Approves Abrysvo for Adults 18-59 at Increased Risk for RSV
Mpox Vaccine Is Safe and Generates a Robust Antibody Response in Adolescents
Latest news about the results of the COVAIL trial regarding the Sanofi booster. GW participated as one of the many sites for this COVID-19 vaccine study.